Genetic polymorphism of dopamine D2 receptors in Parkinson's disease and interactions with cigarette smoking and MAO-B intron 13 polymorphism

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Journal of Neurology Neurosurgery & Psychiatry

• Publication date

  2000-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1136/jnnp.69.4.535PMID 10990520PMCID PMC1737136
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dopamine D2 receptor gene polymorphism and the risk of levodopa-induced dyskinesias in PD.

  1999cited by this paper
• Evidence suggesting the role of specific genetic factors in cigarette smoking.

  1999cited by this paper
• A genetic polymorphism of MAO-B modifies the association of cigarette smoking and Parkinson's disease

  1998cited by this paper
• Case-control study of the D2 dopamine receptor gene and smoking status in lung cancer patients.

  1998cited by this paper
• Association of a polymorphism in intron 13 of the monoamine oxidase B gene with Parkinson disease.

  1998cited by this paper
• The A1 allele of the human D2 dopamine receptor gene predicts low D2 receptor availability in healthy volunteers

  1998cited by this paper
• Evaluation of four candidate genes encoding proteins of the dopamine pathway in familial and sporadic Parkinson's disease

  1997cited by this paper
• D2 dopamine receptor gene (DRD2) Taq1 A polymorphism: reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele.

  1997cited by this paper
• The dopamine D2 receptor (DRD2) gene: a genetic risk factor in smoking.

  1996cited by this paper
• Cigarette smoking and protection from Parkinson's disease

  1995cited by this paper
• D2 dopamine receptor gene and cigarette smoking: a reward gene?

  1994cited by this paper
• No allelic association between Parkinson's disease and dopamine D2, D3, and D4 receptor gene polymorphisms.

  1994cited by this paper
• PCR detection of the TaqA RFLP at the DRD2 locus.

  1993cited by this paper
• Polymorphism in the human dopamine D4 receptor gene (DRD4) in Japanese detected by PCR.

  1993cited by this paper
• The dopamine D2 receptor locus as a modifying gene in neuropsychiatric disorders.

  1991cited by this paper
• Allelic association of the D2 dopamine receptor gene with receptor-binding characteristics in alcoholism.

  1991cited by this paper
• The human dopamine D2 receptor gene is located on chromosome 11 at q22-q23 and identifies a TaqI RFLP.

  1989cited by this paper

• Interaction of Smoking and Genetic Polymorphisms in the Dopaminergic Pathway in Relation to Parkinson’s Disease: A Scoping Review

  2025cites this paper
• Unravelling the neuroprotective mechanisms of carotenes in differentiated human neural cells: Biochemical and proteomic approaches

  2022cites this paper
• Polymorphisms of Dopamine Receptor Genes and Parkinson’s Disease: Clinical Relevance and Future Perspectives

  2021cites this paper
• Influence of serum concentration in retinoic acid and phorbol ester induced differentiation of SH-SY5Y human neuroblastoma cell line

  2020cites this paper
• Association between dopamine receptor D2 TaqIA polymorphism and Parkinson disease risk: a meta-analysis.

  2019cites this paper
• Association between the DRD2 TaqIA gene polymorphism and Parkinson disease risk: an updated meta-analysis

  2019cites this paper
• Inhibition of microRNA-200a Upregulates the Expression of Striatal Dopamine Receptor D2 to Repress Apoptosis of Striatum via the cAMP/PKA Signaling Pathway in Rats with Parkinson’s Disease

  2018cites this paper
• Efficient and biologically relevant consensus strategy for Parkinson’s disease gene prioritization

  2016cites this paper
• INSTITUTE OF NEUROSCIENCE OF CASTILLA Y LEÓN Laboratory of Audiomotor disorders ENGLISH SUMMARY Sensorimotor Alterations in Neurodegenerative Disease

  2015influential citation
• Genetic characterization of cognitive impairment in Parkinson's disease.

  2014cites this paper
• Genomic and pharmacogenomic biomarkers of Parkinson's disease.

  2014cites this paper
• Functional polymorphisms of the MAO gene with Parkinson disease susceptibility: a meta-analysis.

  2014influential citation
• Polymorphisms of DRD2 and DRD3 genes and Parkinson's disease: A meta-analysis.

  2014cites this paper
• Ginkgo biloba extract (EGb 761) modulates the expression of dopamine-related genes in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice.

  2012cites this paper
• Estudio del locus 11q22-q23 y su implicación en variables relacionadas con el aprendizaje y la memoria

  2012cites this paper
• 19. Dopamine Dysregulation Syndrome

  2011cites this paper
• Genetic polymorphisms involved in dopaminergic neurotransmission and risk for Parkinson's disease in a Japanese population

  2011cites this paper
• Association of DRD2 and DRD3 polymorphisms with Parkinson's disease in a multiethnic consortium.

  2011cites this paper
• Association of the DRD2 gene Taq1A polymorphism and smoking behavior: a meta-analysis and new data.

  2009cites this paper
• The ANKK1 Kinase Gene and Psychiatric Disorders

  2009cites this paper
• Dopamine Dysregulation Syndrome

  2008cites this paper
• Gene–environment interactions in sporadic Parkinson's disease

  2006influential citation
• Association of the serotonin transporter promoter polymorphism with smoking behavior among adolescents

  2005cites this paper
• Neurodegenerative Diseases: Parkinson's disease

  2005cites this paper
• Genotype combinations for monoamine oxidase-B intron 13 polymorphism and dopamine D2 receptor TaqIB polymorphism are associated with ever-smoking status among men.

  2005cites this paper
• Polymorphism in candidate genes: implications for the risk and treatment of idiopathic Parkinson's disease

  2004cites this paper
• Advances in molecular genetics and the prevention and treatment of substance misuse: Implications of association studies of the A1 allele of the D2 dopamine receptor gene.

  2004cites this paper
• Progress in searching for susceptibility loci and genes for smoking‐related behaviour

  2004cites this paper
• Monoamine oxidase B polymorphism, cigarette smoking and risk of Parkinson's disease: A study in an Asian population

  2003cites this paper
• Dopamine D2 receptor TaqIA and TaqIB polymorphisms in Parkinson's disease

  2003cites this paper
• The genetic determinants of smoking.

  2003cites this paper
• Parkinson's Disease: Genetic Epidemiology and Overview

  2003cites this paper
• D2 dopamine receptor gene in psychiatric and neurologic disorders and its phenotypes

  2003cites this paper
• Gender difference in the interaction of smoking and monoamine oxidase B intron 13 genotype in Parkinson's disease.

  2002cites this paper
• Substance Misuse

  2001cites this paper